We’d love to connect with you!

We at UroGen^® appreciate your interest in ZUSDURI and would like to offer you the opportunity to stay in touch. Sign up today to be among the first to hear important product updates. Just fill out the form below to stay informed!

Interested in sharing your story or participating in market research? Let us know!

At UroGen we are always interested in hearing from patients with recurrent LG-IR-NMIBC and their caregivers who would like to engage with us to share their personal stories or provide us with feedback. If this is something you would consider, please let us know via the form below.

*Required field.

Please note that this program is intended for US residents only. Are you a US resident?*

Yes, I am a US resident.

First Name*

Last Name*

Email Address* (We use this only to send you the communications you have requested.)

Are you a patient or caregiver?*

Patient

Caregiver

Other

Would you be interested in sharing your story to benefit other patients?

Yes

Would you be interested in participating in market research that might benefit others?

If you are selected for market research, you will be compensated for your time. Your responses will be anonymous.

Yes

By checking this box, I certify that I am at least 18 years old, that I am a resident of the US, that I agree to receive communications from UroGen Pharma, Inc. related to bladder cancer treatment, and that I understand that my information will be processed in accordance with the UroGen Pharma, Inc. Privacy Policy.

For California Residents: By completing this form and submitting it for the purposes of receiving information and updates on bladder cancer treatments, you understand UroGen, Inc.'s California Notice at Collection located at https://www.urogen.com/privacy-policy. To opt-out of the use of this Personal Information, you may email us at Privacy@urogen.com. Only you, or someone legally authorized to act on your behalf, may make an opt-out request.*

We will not sell or transfer your name, address, or any other information to any other party for use in marketing. You may unsubscribe at any time by following the instructions in any communication you receive from us.

LG-IR-NMIBC=low-grade intermediate-risk non-muscle invasive bladder cancer.

APPROVED USE FOR ZUSDURI

ZUSDURI (mitomycin) for intravesical solution is a prescription medicine used to treat adults with a type of cancer of the lining of the bladder called low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) after you have previously received bladder surgery to remove tumor and it did not work or is no longer working.

IMPORTANT SAFETY INFORMATION

You should not receive ZUSDURI if you have a hole or tear (perforation) of your bladder or if you have had an allergic reaction to mitomycin or to any of the ingredients in ZUSDURI.

Before receiving ZUSDURI, tell your healthcare provider about all of your medical conditions, including if you:

have kidney problems
are pregnant or plan to become pregnant. ZUSDURI can harm your unborn baby. You should not become pregnant during treatment with ZUSDURI. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with ZUSDURI.
Females who are able to become pregnant: You should use effective birth control (contraception) during treatment with ZUSDURI and for 6 months after the last dose.
Males being treated with ZUSDURI: You should use effective birth control (contraception) during treatment with ZUSDURI and for 3 months after the last dose.
are breastfeeding or plan to breastfeed. It is not known if ZUSDURI passes into your breast milk. Do not breastfeed during treatment with ZUSDURI and for 1 week after the last dose.

How will I receive ZUSDURI?

You will receive your ZUSDURI dose from your healthcare provider 1 time a week for 6 weeks into your bladder through a tube called a urinary catheter. It is important that you receive all 6 doses of ZUSDURI according to your healthcare provider’s instructions.
If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment.
During treatment with ZUSDURI, your healthcare provider may tell you to take additional medicines or change how you take your current medicines.

After receiving ZUSDURI:

ZUSDURI may cause your urine color to change to a violet to blue color. Avoid contact between your skin and urine for at least 24 hours.
To urinate, males and females should sit on a toilet and flush the toilet several times after you use it. After going to the bathroom, wash your hands, your inner thighs, and genital area well with soap and water.
Clothing that comes in contact with urine should be washed right away and washed separately from other clothing.

The most common side effects of ZUSDURI include: increased blood creatinine levels, increased blood potassium levels, trouble with urination, decreased red blood cell counts, increase in certain blood liver tests, increased or decreased white blood cell counts, urinary tract infection, blood in your urine.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.

Please see ZUSDURI Full Prescribing Information, including the Patient Information, for additional information.

ZUSDURI^™ and UroGen Support^™ are trademarks and UroGen^® is a registered trademark of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.
©2025 UroGen Pharma, Inc. All rights reserved. US-ZUS-00046 06/25
This site is intended for US patients and caregivers.

You are about to leave ZUSDURI.com.
Do you still want to continue?
About UroGen
You are about to leave ZUSDURI.com.
Do you still want to continue?
Contact Us
Sitemap
You are about to leave ZUSDURI.com.
Do you still want to continue?
Privacy Policy
You are about to leave ZUSDURI.com.
Do you still want to continue?
Terms of Use